Interested in using RareSight?
Sign up now and we will let you know when it's available
Our Solution
Making Rare Diagnoses Less Rare
RareSight is developing an AI-powered decision support tool designed to help clinicians identify rare diseases earlier and with greater confidence. Our technology integrates biomedical data and clinical patterns to highlight possible diagnoses that may otherwise be overlooked in day-to-day practice.
Diagnosing rare diseases is incredibly difficult — not because clinicians aren’t skilled, but because these conditions are, by nature, uncommon and complex. Many present with vague, overlapping symptoms, leading to diagnostic delays that can stretch across years. By supporting clinicians with intelligent, pattern-based suggestions, RareSight helps bring rare diseases into view sooner.
Why This Matters
How It Works
Our tool operates quietly in the background of a clinician’s workflow, using structured and unstructured patient data to detect rare disease signals. It’s designed to:
-
Recognize subtle diagnostic patterns across symptoms, labs, history, and more
-
Surface possible rare diseases that match the profile — even if they’re not top-of-mind
-
Provide explainable insights, so clinicians understand why a suggestion was made
-
Integrate with existing systems to minimize friction and support adoption
The goal is not to replace clinical judgment — it’s to give healthcare professionals an extra layer of insight when it’s needed most.
RareSight is designed with and for clinicians. We collaborate closely with doctors, data scientists, and healthcare systems to ensure our tool is clinically relevant, technically robust, and easy to use. Because in real-world care, simplicity and trust matter as much as accuracy.
Built for the Front Line
Looking Ahead
Our current focus is on high-impact rare diseases where early diagnosis can significantly change outcomes. As we grow, we aim to expand our database, deepen our algorithms, and integrate seamlessly across care settings — from primary care to specialist centers.